• Number of patients treated develops positively
• Improved margin year-on-year in Q3 2013; EBITDA increases by 7.2% to €71.4 million
• Promissory note loan (“Schuldscheindarlehen”) of €300 million placed successfully
• Further improvement of balance sheet ratios; increasing equity ratio
The Asklepios Group continued to grow in the first nine months of the 2013 financial year: From January to September, 509,866 inpatients were treated, an increase of 0.5% compared to the same period of the previous year (9M 2012: 507,098). The number of outpatients increased by 8.9% to 1,069,444 (9M 2012: 981,954). High demand for inpatient medical services in the third quarter meant that after nine months Asklepios is now above the previous year here, too. The purely organic growth is also reflected by revenue, which increased by 2.9% to €2,251.0 million (9M 2012: €2,188.1 million).